No abstract available
Keywords:
Aficamten; REDWOOD-HCM; obstructive hypertrophic cardiomyopathy; refractory obstructive hypertrophic cardiomyopathy.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anti-Arrhythmia Agents
-
Cardiomyopathy, Hypertrophic* / drug therapy
-
Disopyramide / adverse effects
-
Heart Failure* / drug therapy
-
Humans
-
Sequoia*
Substances
-
Disopyramide
-
Anti-Arrhythmia Agents